Skip to main content

Table 3 Multivariate analysis for tumor response

From: The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy

Parameters

Odds ratio

95% confidence interval

P value

Good response

   

CEA

1.940

0.822-4.581

0.130

cT

2.580

1.080-6.161

0.033

cN

2.869

1.199-6.864

0.018

EZH2

2.684

1.147-6.280

0.023

Down-staging

   

CEA

1.624

0.735-3.589

0.231

cN

2.915

1.239-6.860

0.025

EZH2

2.476

1.107-5.537

0.027

  1. EZH2: Enhancer of zeste homologue 2; CEA: carcinoembryonic antigen.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us